Market Tracker

10/21 6:05pm ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

During the Trading Day
140.55 -1.44 / -1.01%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
140.55 0.00 / 0.00%
 
Volume: 14.4K

Today’s Trading

Previous close141.99
Today’s open142.93
Day’s range138.86 - 143.51
Volume1,017,399
Average volume (3 months)1,848,126
Market cap$9.0B
Dividend yield--
Data as of 3:59pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+64.14%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+26.98%
P/E ratio167.3
Price/Sales5.95
Price/Book12.06

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+6.96+4.57%
ENDPEndo International P...+2.28+3.72%
PCYCPharmacyclics Inc+1.73+1.51%
INCYIncyte Corp+1.65+3.25%
Data as of 4:14pm ET, 10/21/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$1.55
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Executive VP-Finance &
Administration
Adam C. Derbyshire
Corporate headquarters
Raleigh, North Carolina

Forecasts